Clasificación geográfica

Europa > España

Movimientos socio-culturales

Grupos por ámbito de dedicación

Científicas > Biólogas > Biomédicas

Sanitarias > Farmacéuticas

Escritoras > Periodistas / Cronistas > Críticas literarias, musicales, etc.

Personaje
Imagen

Teresa Gonzalo Lázaro

Madrid 1977

Periodo de actividad: Desde 2009 hasta Aún activa

Clasificación geográfica: Europa > España

Movimientos socio-culturales

Grupos por ámbito de dedicación

Científicas > Biólogas > Biomédicas

Sanitarias > Farmacéuticas

Escritoras > Periodistas / Cronistas > Críticas literarias, musicales, etc.

Contexto de creación femenina

There is a long tradition of women throughout history, with extraordinary knowledge about the healing power of plants and their medicinal uses. They were the ones who provided the first pharmaceutical, hygienic and medical care. There are figures such as Hildegard of Bingen, abbess of the 12th century, who among many other texts, wrote "Causes and solutions", a medical text with recommendations and medicinal uses for different diseases.

In Spain, despite the difficulties for women to access the University (Concepción Arenal, in 1841, went to the Faculty of Law dressed as a man, in order to attend the class), there are data on women graduates in pharmacy since the nineteenth century. In the 1930s, the female quota in the Official College of Pharmacists of Madrid reached 25% of the total membership. There were Josefa Bonald (Madrid, 1893), who registered fourteen medicines between 1923 and 1935, or Rosa Martín de Antonio (Guadalajara, 1891), affiliated to the Republican Party and exiled to Venezuela during the civil war. Teresa Gonzalo Lázaro belongs to a new generation of pharmacists who, like many of her predecessors, has managed to develop a substance, a gel, of great interest for women's health, as it prevents the spread of HIV. Teresa Gonzalo has two world patents, the result of research at the University of Santiago together with the scientist and university professor María José Alonso Fernández.

Reseña

Graduated in Pharmacy and doctor in Biomedicine, with an MBA in Biotechnological Management. Specialised in cancer and AIDS, she has developed a gel for topical vaginal use to prevent the spread of HIV.
As the co-founder of the company Ambiox Biotech, she received the MIT TR35 award for developing this prevention method. This method may be very important in those situations where women find it difficult to use condoms in a consensual way.

Actividades

Inglés

  • Ending the AIDS pandemic
    • España > Biología y Geología > 1º ESO > Hábitos saludables
    • España > Biología y Geología > 3º ESO > Hábitos saludables

Español

  • Acabemos con la pandemia de SIDA
    • España > Biología y Geología > 1º ESO > Hábitos saludables
    • España > Biología y Geología > 3º ESO > Hábitos saludables

Justificaciones

  • Spanish researcher and scientist, co-author of two world patents.
  • She has developed a form of protection against AIDS, not linked to the use of condoms, with which women can protect themselves independently. This method is cheap and quite effective (80 %).
  • Co-founder and CEO of Ambiox Biotech, which intends to distribute this method of protection, especially in areas of the planet where the disease is more important and where women are more unprotected.
  • She has been recognised for her charitable work.

Biografía

Born in Madrid in 1977, she graduated in 2001 in Pharmacy from the University of Alcalá. Later, she obtained a doctorate (2006) in Biomedicine at the University of Groningen (The Netherlands). In 2009 she completed an MBA in biotechnological management, after which she continued her research at the University of Santiago de Compostela, mainly on cancer and AIDS. The result of these investigations are two world patents for nanocapsules for pharmaceutical use, of which she is a co-author.

Thanks to her research on HIV, she developed a topical vaginal gel to prevent infection. As she herself states in different interviews, this gel can represent a great advance for women in situations where the use of condoms is not agreed upon, since they will not have to negotiate their use to obtain protection against AIDS. As a result of the development of this product, in 2011 she was awarded the TR35 Prize of "Solidarity Innovator", from the prestigious Massachusetts Institute of Technology (MIT). In 2011 she also participated in the foundation, together with three other colleagues, of the company Ambiox Biotech label, which is in charge of biomedical patents, and of which she is the general director. From this company they try to market the developed gel, trying to get it to geographical areas with scarce resources and difficulties in the use of condoms.

Currently, in addition to working in her own company, she continues her research work as Director of Medical Science at VERTESS, in California, United States, where she continues her work to develop different pharmaceutical, diagnostic and medical technology products.

 

Obras


She is dedicated to patents and to the direction of biomedical companies.
She is co-author of some research articles.

Enfoque Didáctico

·      Biology and geology of 3º of ESO.

Documentos